Riitta Lassila: How APAC Impacts the Interplay Between Complement and Coagulation
Riitta Lassila, Professor of Coagulation Medicine at University of Helsinki, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Our team has published about how the heparin proteoglycan mimic APAC impacts the interplay between complement system and coagulation.
The regulatory functions and cellular clearance of debris are supported – an anti-inflammatory effect aligning with the antithrombotic mechanisms of APAC (by Aplagon).”
Title: Interactions of Antiplatelet, Anticoagulant (APAC) with C1q and FH modulate complement activation on injured cells
Authors: Juha Kotimaa, Mikel Artero Rezola, Annukka Jouppila, Riitta Lassila, Seppo Meri
Read the Full Article on Blood Vessels, Thrombosis and Hemostasis.
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning